A multidisciplinary team of University of Miami researchers studying factors associated with health outcomes and disease risk in the Hispanic community has received a $21 million grant from the ...

(Reuters) - Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of ...

The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications ...

A recent study published in Synthese challenges the default collection and reliance on ethno-racial data in biomedical ...

As a wellness writer who spends a bit too much time analyzing indigent lists and scrolling on TikTok, there’s hardly anything ...

NXC-201 is a sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy. Initial data from Phase 1b/2 ex-U.S. study NEXICART-1 has demonstrated high complete response rates ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

IROS and Halia Therapeutics’ clinical trial will explore a promising new therapy for obesity, specifically designed to ...

Zoonotic diseases, also known as zoonoses, bridge the gap between animal and human health, marking a prominent area of concern for global public health.

Valley Medical Center next month will open the first phase of a new cancer facility that will increase its capacity to treat ...

Learn about clinical trials, from preclinical studies to Phase IV trials. Explore the different clinical trial phases (I-III) ...